Skip to main content
. 2024 Dec 11;12:1493794. doi: 10.3389/fpubh.2024.1493794

Table 2.

General baseline characteristics of the participants by overactive bladder or non-overactive bladder in the NHANES 2011–2018a.

Characteristic Total Non-overactive bladder Overactive bladder P-value
(n = 4,451) (n = 3,416) (n = 1,035)
Age (years), mean (SE) 46.46 ± 0.33 43.96 ± 0.36 56.47 ± 0.61 <0.001
Sex (%) <0.001
Male 50.23 (48.20, 52.25) 54.06 (51.78, 56.33) 34.89 (30.76, 39.27)
Female 49.77 (47.75, 51.80) 45.94 (43.67, 48.22) 65.11 (60.73, 69.24)
Race (%) <0.001
Non-Hispanic White 68.12 (66.54, 69.66) 68.08 (66.3, 69.81) 68.29 (64.84, 71.55)
Non-Hispanic Black 10.50 (9.76, 11.29) 9.74 (8.94, 10.60) 13.56 (11.76, 15.58)
Mexican American 7.77 (7.06, 8.54) 7.96 (7.15, 8.85) 7.01 (5.73, 8.54)
Non-Hispanic Asian 4.63 (4.21, 5.10) 5.11 (4.61, 5.67) 2.72 (2.09, 3.53)
Hispanic 5.74 (5.13, 6.41) 5.77 (5.08, 6.54) 5.61 (4.41, 7.12)
Other Race 3.23 (2.63, 3.98) 3.34 (2.67, 4.17) 2.81 (1.61, 4.89)
Educational level (%) <0.001
Below high school 11.62 (10.66, 12.65) 10.59 (9.56, 11.72) 15.70 (13.42, 18.29)
High school 22.09 (20.43, 23.85) 21.87 (20.01, 23.86) 22.94 (19.46, 26.85)
Some college or AA degree 32.27 (30.44, 34.15) 31.64 (29.61, 33.74) 34.78 (30.76, 39.04)
College graduate or above 34.03 (32.04, 36.08) 35.89 (33.64, 38.21) 26.57 (22.50, 31.08)
Marital status (%) 0.016
Married or living with a partner 36.96 (35.07, 38.90) 36.79 (34.65, 38.98) 37.65 (33.67, 41.81)
Living alone 63.04 (61.10, 64.93) 63.21 (61.02, 65.35) 62.35 (58.19, 66.33)
Socioeconomic status (%) <0.001
Low 20.49 (19.17, 21.88) 19.19 (17.73, 20.73) 25.7 (22.63, 29.02)
Moderate 33.33 (31.51, 35.2) 32.43 (30.40, 34.52) 36.95 (32.91, 41.19)
High 46.18 (44.12, 48.25) 48.38 (46.08, 50.69) 37.35 (32.87, 42.05)
BMI (%) <0.001
<25 kg/m2 29.53 (27.73, 31.41) 32.03 (29.94, 34.19) 19.54 (16.44, 23.07)
25–30 kg/m2 32.42 (30.53, 34.37) 33.03 (30.91, 35.23) 29.96 (25.93, 34.33)
≥30 kg/m2 38.05 (36.10, 40.03) 34.94 (32.79, 37.15) 50.50 (46.11, 54.88)
Smoking status (%) <0.001
Never 57.88 (55.86, 59.86) 59.04 (56.77, 61.28) 53.20 (48.83, 57.52)
Former 23.09 (21.38, 24.90) 22.24 (20.33, 24.27) 26.51 (22.82, 30.56)
Current 19.03 (17.56, 20.59) 18.72 (17.06, 20.49) 20.29 (17.26, 23.70)
Alcohol intake (%) 0.001
Low 10.42 (9.38, 11.56) 9.49 (8.41, 10.68) 14.17 (11.44, 17.41)
Moderate 39.75 (37.75, 41.78) 39.78 (37.53, 42.07) 39.61 (35.33, 44.06)
High 49.83 (47.8, 51.86) 50.74 (48.45, 53.02) 46.22 (41.90, 50.60)
Hypertension (%) <0.001
No 85.76 (84.33, 87.09) 87.57 (86.01, 88.98) 78.54 (74.85, 81.81)
Yes 14.24 (12.91, 15.67) 12.43 (11.02, 13.99) 21.46 (18.19, 25.15)
Diabetes (%) <0.001
No 89.82 (88.59, 90.93) 92.08 (90.77, 93.22) 80.78 (77.43, 83.73)
Yes 10.18 (9.07, 11.41) 7.92 (6.78, 9.23) 19.22 (16.27, 22.57)
Hypercholesterolemia (%) 0.366
No 88.48 (87.05, 89.77) 88.87 (87.26, 90.30) 86.91 (83.58, 89.64)
Yes 11.52 (10.23, 12.95) 11.13 (9.70, 12.74) 13.09 (10.36, 16.42)
Cardiovascular disease (%) <0.001
No 92.69 (91.65, 93.62) 94.67 (93.58, 95.59) 84.77 (81.73, 87.39)
Yes 7.31 (6.38, 8.35) 5.33 (4.41, 6.42) 15.23 (12.61, 18.27)
High molecular phthalates (ng mL −1 ) mean (SE)
MCNP 4.43 ± 0.43 4.2 ± 0.26 5.33 ± 1.88 0.733
MCOP 35.8 ± 1.85 37.93 ± 2.19 27.29 ± 2.94 <0.001
MECP 12.25 ± 0.5 12.23 ± 0.59 12.32 ± 0.88 0.062
MCPP 5.93 ± 0.61 6.05 ± 0.72 5.46 ± 0.95 0.610
MBzP 8.18 ± 0.32 7.94 ± 0.36 9.12 ± 0.71 0.031
Low molecular phthalates (ng mL1) mean (SE)
MEP 147.31 ± 12.73 146.5 ± 14.81 150.56 ± 23.26 0.702
MBP 16.03 ± 1.07 16.05 ± 1.31 15.96 ± 1.03 0.847
MiBP 15.24 ± 0.59 13.53 ± 0.67 15.67 ± 0.72 0.040
OABSS score, mean (SE) 1.49 ± 0.03 0.92 ± 0.02 3.73 ± 0.04 <0.001

aParticipants included in Model 3.

HMW, high molecular weight; LMW, low molecular weight; MCNP, mono(carboxynonyl)phthalate; MCOP, mono(carboxyoctyl) phthalate; MECP, Mono-2-ethyl-5-carboxypentyl phthalate; MCPP, mono-(3-carboxypropyl) phthalate; MBzP, mono-benzyl phthalate; MEP, mono-ethyl phthalate; MBP, mono-n-butyl phthalate; MiBP, mono-isobutyl phthalate.